Mechanistic PKPD Models of Protein Therapeutics for Early Clinical Development
Fei Hua, Ph.D.; Daniel Kirouac, Ph.D.; Lore Gruenbaum, Ph.D.; John Burke, Ph.D.; Joshua Apgar, Ph.D. AAPS News Magazine (2018).
Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1
Joshua F. Apgar , Jian-Ping Tang, Pratap Singh, Nanda Balasubramanian, John Burke, Michael R. Hodges, Melissa A. Lasaro, Lin Lin, Bjorn L. Miliard, Kristi Moore, Lucy S. Jun, Susan Sobolov, Anna Katharina Wilkins and Xiang Gao (2018).
Intrahepatic transcriptional signature associated with response to interferon-alpha treatment in the woodchuck model of chronic hepatitis B
Fletcher, S.P., Chin, D.J., Gruenbaum, L., Bitter, H., Rasmussen, E., Ravindran, P., Swinney, D.C., Birzele, F., Schmuki, R., Lorenz, S., Kopetzki, E., Carter, J., Triyatni, M., Thampi, L.M. Yang, J., AlDeghaither, D., Murredu, M.G., Cote, P. and Menne, S. (2016).
PMID: 27022978
BI 885578, a Novel IGF1R/INSR Tyrosine Kinase Inhibitor with Pharmacokinetic Properties That Dissociate Antitumor Efficacy and Perturbation of Glucose Homeostasis
Sanderson MP, Apgar J, Garin-Chesa P, Hofmann MH, Kessler D, Quant J, Savchenko A, Schaaf O, Treu M, Tye H, Zahn SK, Zoephel A, Haaksma E, Adolf GR, Kraut N. (2015).
PMID: 26438154
An Introduction to the Regulatory and Nonclinical Aspects of the Nonclinical Development of Antibody Drug Conjugates
Lansita J. A., Burke J. M., Apgar J. F., Mounho-Zamora B. (2015).
PMID: 26108879
Identification of six cell surface proteins for specific liver targeting
Ducret, A., Kux van Geijtenbeek, S., Röder, D., Simon, S., Chin, D., Berrera, M., Gruenbaum, L., Ji, C., Cutler, P. (2015).
PMID: 26097162
Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system
1. S. E. Wheeler, A. M. Clark, D. P. Taylor, C. L. Young, V. C. Pillai, D. B. Stolz, R. Venkataramanan, D. Lauffenburger, L. Griffith, A. Wells (2014).
PMID: 25314052